33 Most existing cancer treatments involve high-cost chemotherapy and radiotherapy, 34 with major side effects, prompting effort to develop alternative treatment modalities.
134
The CGA were dissolved in dimethyl sulfoxide (DMSO) (Sigma) and stored at -20°C.
135
The stocks were diluted with a culture medium to the indicated final concentration for 136 treatment before usage. Cells were incubated overnight at 37°C and then treated with 137 various concentrations of the CGA. The experimental setup and administration of 138 TC-HT (10-cycles) and LIPEF (60 V/cm; 2 Hz) have been previously described [7, 14] 139 with optimum results. Therefore, the same parameters of TC-HT and LIPEF systems 140 were selected for subsequent experiments. The TC-HT was performed by using a 141 modified PCR system to achieve a series of short period of heat exposure within the 142 desired time. In our experimental design of TC-HT, the protruded portion of culture 143 well was cut off for better immersion in water bath consisting of the heat sink of PCR 144 machine, and the temperature experienced by cells was measured by a needle 145 thermocouple. The PANC-1 cells were subjected to the cycling temperature from 43.5 146 to 36 °C. In order to return the temperature of the cancer cells seeded in culture well 147 to physiological temperature after each thermal exposure, active cooling environment 148 is needed to be involved for enabling such a bulk (culture well) to dissipate heat 149 quickly in vitro. In the experimental design of LIPEF, two copper parallel electrodes 150 separated by air gap presents a non-contact means to build up an electric field passing through biological sample. For the double treatments of CGA and physical stimulus,
152
CGA-treated cells were subjected to TC-HT or LIPEF. The double treatment of 153 physical stimuli was performed by exposing the cells to the TC-HT first and then to 154 the LIPEF. In the triple treatment, cells in a medium containing CGA were exposed to 155 the TC-HT followed by the LIPEF. The timeline of combined treatment procedures is 
175
The colonies containing more than 50 cells were counted, and the number of colonies 176 in each treatment group was normalized to control group.
178

Flow cytometric analysis of apoptosis 179
After single or combined treatment for 24 h, the apoptosis of PANC-1 cells was 180 determined by using the Annexin V-FITC/PI apoptosis detection kit (BD Biosciences).
181
The cells were harvested with trypsin-EDTA (Gibco) and collected by centrifugation 182 at 2,000 × g for 5 min, washed twice with cold PBS, and resuspended in binding 
258
Interestingly, the viability of H6c7 pancreatic normal cells was not affected under the 259 same conditions (Fig 1D) , suggesting that the triple treatment may cause specific 260 cytotoxicity to cancer cells. Next, we continued to adopt 200 μM CGA and performed 261 a clonogenic assay to confirm the effects of TC-HT (10-cycles) and/or LIPEF (60 262 V/cm) on CGA-treated cells. Our results revealed a marked suppressive effect on 263 colony formation of PANC-1 cells subjected to triple combination treatment (Fig 2A   264 and 2B), which is in agreement with the MTT cytotoxic data. 
360
Meanwhile, the protein levels of cleaved caspase-9 and PARP cleavage were 361 increased (Fig 5C and 5D) . Furthermore, we also found that p53 and p21 protein 362 expression levels in the PANC-1 cells subjected to the triple treatment were 363 significantly higher than those of the control cells or than those of the double 364 combination treatment (CGA+LIPEF, CGA+TCHT, or LIPEF+TC-HT) (Fig 5E and   365  5F) . These data elucidate a pathway of growth arrest and mitochondrial apoptosis in The role of ROS production in the triple treatment-induced 370 anticancer effect 371 We next measured intracellular ROS generation within the cells using a fluorescent 372 probe DHE to reveal that whether oxidative stress is involved in the induction of 373 apoptosis in PANC-1 cells. As shown in Fig 6A and 6B, 
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Therefore, an addition of NAC was able to significantly inhibit cell death signals in 386 the presence of triple treatment, as evidenced by western blot analysis. Furthermore, the induced expression of proteins Bax, p21, and p53 as well as the reduced 388 expression of Bcl-2 protein caused by triple treatment were blocked following the 389 pretreatment with NAC, as shown in Fig 6D and 6E. These results indicate that ROS previous study by our team [22] . In this study, we further propose another modality,
432
combining CGA, TC-HT, and LIPEF, with proof for its significant effect in 433 combating pancreatic cancer.
434
The study also looks into the anti-proliferative and pro-apoptotic activities of (Fig 3) . The activation of caspase-9 and cleavage of PARP (Fig 5B-5D) . P53, also an important 471 activator of the mitochondrial apoptotic pathway, was shown to regulate the 472 expressions of Bcl-2 and Bax in vitro and in vivo [29] . Thus, the up-regulation of p53 found in our experiments may be the cause for the imbalanced Bax/Bcl-2 ratio in the 474 PANC-1 cells treated with triple treatment (Fig 5B and 5E) 
486
Therefore, the repetition frequency and the field intensity of LIPEF may both play an 487 key role in the synergy actions. Given the fact that the electric field can be modified 488 to focus on the target area, non-contact LIPEF stimulus featuring simultaneous 489 multi-frequency components to induce beneficial bioeffects appears to be a promising therapeutic approach.
491
Several studies have indicated that ROS production plays a crucial role in cell 492 cycle progression and apoptosis [31, 32] . On the other hand, it has been found that 493 CGA displays anticancer activity through ROS generation and subsequent induction 494 of apoptosis in cancer cells [33, 34] . In this study, triple treatment significantly 495 stimulated the production of ROS in PANC-1 cells (Fig 6A and 6B) we pretreated the cells with NAC, a ROS scavenger. In response to NAC pretreatment,
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triple treatment-induced cell death was attenuated (Fig 6C) . Moreover, the triple 503 treatment-stimulated expression of p53 was reduced in the NAC-pretreated cells ( Fig   504  6D and 6E) . The other p53-associated proteins, including Bax and p21, were also 505 decreased by the addition of NAC (Fig 6D and 6E) . By contrast, the anti-apoptotic 506 protein Bcl-2 reduced by triple treatment was recovered following NAC treatment. 
515
The study first reveals that non-invasive treatment via TC-HT and LIPEF could 516 serve as anticancer agent in synergy with natural compound to selectively cause 517 cancer cell death, with an effect comparable to chemotherapeutic drugs. In in vivo 518 experiment, high-intensity focused ultrasound (HIFU) might be a suitable thermal 519 source for TC-HT. Thanks to the ability to fine tune thermal parameters by 520 modulating the heating power and the size of the heated region via multi-focal HIFU,
521
it has been proven to be applicable for mild HT therapy in tumor [38] . This thermal 522 technique is able to control the heated tumor area to only about 4-8 mm [39, 40] , 523 much smaller than surrounding bulk tumor/tissue mass, as a result of which heat can 524 quickly dissipate in the passive cooling environment of human body. In operation, the size of scan spot (the heated area) and the heating intensity adopted by multi-focal 526 HIFU in the scanning mode can be tunable so as to achieve effective thermal 527 dissipation necessary for application of TC-HT in vivo. As for other cycling 528 parameters that require a higher thermal dissipation rate, active cooling devices can be 529 incorporated for pre-cooling [41] . Therefore, the combination modality of TC-HT and 530 LIPEF along with natural compound CGA appears to be a potent approach for 531 treatment of pancreatic cancer with the potential of improving the life quality of such 532 patients. This new method provides a means of mild anticancer treatment by 533 alleviating the side effects associated with prolonged thermal exposure and direct 534 contact with electrodes. However, the synergetic effect of non-invasive thermal and 535 electrical stimuli on CGA may vary among different cancer cells. Therefore, further 536 studies are needed to establish its benefits in other cancer cell lines.
537
In summary, the study puts forth a unique triple treatment combining CGA, 
